ALPN: Alpine Immune Sciences, Inc. Stock

by  •  • Comments Off on ALPN: Alpine Immune Sciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-21 13D/A Frazier Life Sciences VIII, L.P. 0.00 -100.00
05-21 13D/A Decheng Capital China Life Sciences USD Fund III, L.P. 0.00 -100.00
03-07 13G/A BlackRock Inc. 4.60 -1.05
02-14 13G/A Lynx1 Capital Management LP 6.60 22.00
02-14 13G/A Cormorant Asset Management, LP 4.39 -10.53
02-14 13G/A Paradigm Biocapital Advisors LP 5.50 37.07
02-14 13G/A Omega Fund VI, L.P. 0.00 -100.00
02-14 13G/A Ra Capital Management, L.p. 9.99 34.24
02-14 13G/A Great Point Partners Llc 6.37 1.81
12-29 13D/A Orbimed Advisors Llc 4.60 -36.58
11-14 13D/A Alpine ImmunoSciences, L.P. 7.20 9.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2024-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
ACAB – Atlantic Coastal Acquisition Corp. II ACET – Adicet Bio, Inc.
ACIU – AC Immune SA ACRV – Acrivon Therapeutics, Inc.
ADMA – ADMA Biologics, Inc.


Financial data and stock pages provided by
Fintel.io